Cooperative Agreement NU58DP006625

The Department of Health and Human Services Centers for Disease Control and Prevention awarded the University of Illinois a cooperative agreement valued at $700,000 on September 30, 2025, under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988). The award funds a two-year project running through September 29, 2027, with place of performance in Illinois. The project establishes federally qualified health centers as bridges between clinical care and community-based trusted...

The Centers for Disease Control and Prevention awarded Ann & Robert H Lurie Children's Hospital of Chicago a $499,971 cooperative agreement on September 30, 2025, under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) to establish and operate a diabetes surveillance system for the Chicago area with representative ascertainment. The hospital, through its Office of Sponsored Programs, will conduct Chicago Area Surveillance, Statistics, and Analysis Network for Diabetes...

The Centers for Disease Control and Prevention awarded a cooperative agreement valued at $699,943 to University of California, Berkeley on September 30, 2025, to examine social connectedness and the impact of the CMS Accountable Health Communities Model on racial equity of diabetes care. The award is issued under the Diabetes Prevention and Control Programs (CFDA 93.988), which funds efforts to prevent diabetes and its complications and disabilities. The recipient will conduct research in...

The Centers for Disease Control and Prevention awarded Clemson University a $700,000 cooperative agreement on September 30, 2025, to evaluate the Health Extension for Diabetes Program, a community-clinical linkage model designed to prevent diabetes and its complications through structured community-based intervention. Under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988), Clemson's Division of Research will conduct evaluation activities through September 29, 2027, with...

The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of California, Los Angeles $616,107 on March 10, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct an intersectional analysis of the Whole Person Care–Los Angeles (WPC-LA) social care intervention on diabetes quality of care, glycemic control, complications, and healthcare utilization. UCLA will evaluate the long-term effectiveness of WPC-LA,...

The National Institute for Minority Health and Health Disparities awarded The University of Chicago $830,875 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and evaluate a primary care model addressing interconception care—healthcare services provided after pregnancy to support optimal outcomes in future pregnancies. The award supports research on how primary care providers can address treatable chronic diseases including diabetes,...

The Centers for Disease Control and Prevention awarded Emory University a $500,000 cooperative agreement on September 30, 2025, to establish a nationwide diabetes surveillance system for youth and young adults, tracking incidence, prevalence, risk factors, disparities, and social determinants of health under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988). Work is performed in Georgia. The period of performance runs through September 29, 2027. Children's Healthcare of...

The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Illinois $160,575 on July 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant K01DK147658). The award funds a three-year study of Medicaid alternative payment model (APM) implementation and evidence-based practice adoption in federally qualified health centers (FQHCs) to improve diabetes outcomes. The research addresses how FQHCs, which...

The National Institute of Diabetes and Digestive and Kidney Diseases awarded Albert Einstein College of Medicine $827,240 on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a 12-month randomized controlled trial testing an enhanced community health worker model for improving continuous glucose monitoring uptake and addressing health-related social needs among people with type 2 diabetes in primary care settings. The...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded the University of Utah a $2.014 million Cooperative Agreement (U48DP006956) on September 30, 2025, under the Diabetes Prevention and Control Programs (CFDA 93.988). The award funds the Enhanced Visibility, Engagement, and Reach of Lifestyle Change Interventions Project (EVER-LCI) and LCIRN Coordinating Center through September 29, 2029, with performance based in Salt Lake City, Utah. The program...